Slide background
TAmiRNA – Triple A research and development of RNA diagnostics and therapeutics
Slide background
TAmiRNA – Introducing personalized medicine to Aging
Slide background
TAmiRNA – Harnessing the power of microRNAs for development of innovative diagnostic and therapeutic tools
Slide background
TAmiRNA – Helping to enhance your stability and quality of life with advanced age

partners & investors

Vivomicx Logo


Partner in preclinical drug discovery and  drug development

Austria Wirtschaftsservice GmbH (AWS)

Seed and Pre-Seed financing of TAmiRNA

Die Österreichische Forschungsförderungsgesellschaft FFG

"Basisprogramm" financing of R&D cooperations of TAmiRNA.



Worldwide Distribution partner

SimplicityBio Logo


Partner in biomarker development services.

Cardiolinc Logo


Partner for collaborating on projects and translational research.


7th Framework Program EU-funded project

The SME Instrument - Horizon 2020

The SME instrument (Horizon 2020) offers seamless business innovation support from idea to market, covering the three stages of the full innovation cycle (proof-of-concept, innovation development and commercialisation).


Partner in technology and assay development for rapid microRNA quantification


Partner for assay development and functional in vitro screenings of microRNAs that are associated with age-related disorders.

Grillari Labs

Partner in development of basic research models to gain a better understanding microRNA function in age-related disorders such as Osteoporosis, Cardiovascular Disease or Neurodegenerative Disease

Evercyte GmbH

Partner in the application of pre-clinical models for toxicity and efficacy testing of novel drug candidates

Transform Science

Partner for the implementation of quality driven processes.

OK Consulting

Partner for strategic business development of TAmiRNA.


Click here for your personalized microRNA service offer!